A construction worker and a software engineer both pay into Social Security their entire careers. Under current law, they both wait until age 67 to collect full benefits. A new bill introduced in Congress argues Read more…
Cathie Wood is returning to one of her most familiar plays, in buying a high-conviction growth stock while other investors remain indecisive. On Sept. 22, ARK Invest scooped up Rocket Lab (RKLB) shares worth $25.13 Read more…
$90+ barrel oil and a 10-year Treasury yield near 5% are raising anxieties on Wall Street. But while some investors may think waiting on the sidelines is the safest strategy, Kevin Mahn, president and chief Read more…
For four years, I ran part of my family’s scaffolding business and had to plan shipping rental orders to our customers. When diesel and gas prices rose, that cut into the bottom line, as rental Read more…
A McDonald’s drive-thru shouldn’t feel like a waiting room. Yet there you are, watching the minutes tick by while the car ahead sits at the speaker. For a company with 45,356 restaurants, that is definitely Read more…
Apple just released the iPhone 18 Pro and its first foldable iPhone, but the next big iPhone rumor is already giving investors something to watch. Apple could reportedly skip the iPhone 19 and jump directly Read more…
Wholesale giant Costco is set to report after the closing bell on Sept. 24, 2026, with the results offering a glimpse into the health of the broader U.S. economy. Here are the results that analysts Read more…
Americans are holding onto their automobiles longer, and that ought to be good news for companies that sell the parts required to keep those vehicles functioning. But new figures from AutoZone (AZO) tell a deeper Read more…
At the start of September, Brazilian airline Total Linhas Aéreas stopped operating after its air operator’s certificate (AOC) was suspended by Brazil’s Agência Nacional de Aviação Civil (ANAC). The suspension followed a safety audit that Read more…
Investor days are usually a chance for a company to reassure shareholders. Novo Nordisk (NVO) did the opposite on Monday, September 21. The Danish drugmaker behind Wegovy and Ozempic gathered analysts in London to explain Read more…